Cardiac hypertrophy and oxidative stress: A leap of faith or stark reality?

Heart

Volumn 87, Issue 4, 2002, Pages 316-318

  Lang, Derek ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; SIMVASTATIN;

ATHEROSCLEROSIS; CORRELATION ANALYSIS; DIABETES MELLITUS; ENZYME ACTIVITY; HEART HYPERTROPHY; HUMAN; HYPERCHOLESTEROLEMIA; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0036213604     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.87.4.316     Document Type: Short Survey

References (16)

1. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia
2. Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency
3. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium
4. Disabled early recruitment of antioxidant defenses in Friedreich's ataxia
5. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: An in vivo 31P magnetic resonance spectroscopy study
6. Signal transduction in cardiac hypertrophy - Dissecting compensatory versus pathological pathways utilizing a transgenic approach
7. Coronary microvascular endothelial cell redox state in left ventricular hypertrophy: The role of angiotensin II
8. Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs
9. Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: Role of reactive oxygen species and NADPH oxidase
10. Paracrine and autocrine effects of nitric oxide on myocardial function
11. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats
12. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure
13. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis
14. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy
15. 17Beta-estradiol attenuates the development of pressure-overload hypertrophy
16. The roles of gender, the menopause and hormone replacement on cardiovascular function